| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | acrosomal vesicle | 1.44e-04 | 206 | 51 | 5 | GO:0001669 | |
| Domain | DUF4599 | 3.90e-06 | 12 | 50 | 3 | PF15371 | |
| Domain | DUF4599 | 3.90e-06 | 12 | 50 | 3 | IPR027970 | |
| Domain | NUT | 6.99e-05 | 5 | 50 | 2 | IPR024310 | |
| Domain | NUT_N | 6.99e-05 | 5 | 50 | 2 | IPR024309 | |
| Domain | NUT | 6.99e-05 | 5 | 50 | 2 | PF12881 | |
| Domain | - | 5.91e-04 | 391 | 50 | 6 | 2.30.29.30 | |
| Domain | DH_1 | 6.40e-04 | 63 | 50 | 3 | PS00741 | |
| Domain | PH | 8.64e-04 | 278 | 50 | 5 | SM00233 | |
| Domain | RhoGEF | 8.71e-04 | 70 | 50 | 3 | PF00621 | |
| Domain | DH_2 | 8.71e-04 | 70 | 50 | 3 | PS50010 | |
| Domain | PH_DOMAIN | 8.78e-04 | 279 | 50 | 5 | PS50003 | |
| Domain | PH_domain | 8.92e-04 | 280 | 50 | 5 | IPR001849 | |
| Domain | DH-domain | 9.08e-04 | 71 | 50 | 3 | IPR000219 | |
| Domain | - | 9.08e-04 | 71 | 50 | 3 | 1.20.900.10 | |
| Domain | PH_dom-like | 9.24e-04 | 426 | 50 | 6 | IPR011993 | |
| Domain | RCC1/BLIP-II | 1.71e-03 | 23 | 50 | 2 | IPR009091 | |
| Domain | 6-blade_b-propeller_TolB-like | 6.74e-03 | 46 | 50 | 2 | IPR011042 | |
| Pubmed | 7.19e-11 | 6 | 53 | 4 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 7.19e-11 | 6 | 53 | 4 | 25930072 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | KIAA1671 TANC2 DLG5 IRS4 IGF1R FAM171A2 ALS2 ALPK1 ARHGEF17 TRIP11 BICC1 PHLDB2 | 5.16e-09 | 861 | 53 | 12 | 36931259 |
| Pubmed | 4.99e-08 | 24 | 53 | 4 | 32212159 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 11316748 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 22456610 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 29225160 | ||
| Pubmed | The clinical phenotype of YWHAE-NUTM2B/E positive pediatric clear cell sarcoma of the kidney. | 6.83e-06 | 3 | 53 | 2 | 26542179 | |
| Pubmed | Characterization of insulin receptor substrate 4 in human embryonic kidney 293 cells. | 6.83e-06 | 3 | 53 | 2 | 9553137 | |
| Pubmed | A unique set of SH3-SH3 interactions controls IB1 homodimerization. | 2.27e-05 | 5 | 53 | 2 | 16456539 | |
| Pubmed | 6.34e-05 | 8 | 53 | 2 | 19563800 | ||
| Pubmed | IRS2 signalling is required for the development of a subset of sensory spinal neurons. | 8.15e-05 | 9 | 53 | 2 | 22288475 | |
| Pubmed | Insulin-like growth factor axis gene polymorphisms and clinical outcomes in pancreatic cancer. | 1.02e-04 | 10 | 53 | 2 | 20416304 | |
| Pubmed | Insulin-like growth factor axis gene polymorphisms modify risk of pancreatic cancer. | 1.02e-04 | 10 | 53 | 2 | 21852217 | |
| Pubmed | Interaction of a mitogen-activated protein kinase signaling module with the neuronal protein JIP3. | 1.02e-04 | 10 | 53 | 2 | 10629060 | |
| Pubmed | Local insulin-like growth factor I expression is essential for Purkinje neuron survival at birth. | 1.24e-04 | 11 | 53 | 2 | 20596079 | |
| Pubmed | One tissue, two fates: molecular genetic events that underlie testis versus ovary development. | 1.49e-04 | 12 | 53 | 2 | 15211353 | |
| Pubmed | Multiple glycolytic enzymes are tightly bound to the fibrous sheath of mouse spermatozoa. | 1.49e-04 | 12 | 53 | 2 | 16687649 | |
| Pubmed | MAP3Ks as central regulators of cell fate during development. | 2.36e-04 | 15 | 53 | 2 | 18855897 | |
| Pubmed | 4.25e-04 | 20 | 53 | 2 | 12897243 | ||
| Pubmed | 4.52e-04 | 421 | 53 | 5 | 36976175 | ||
| Pubmed | 5.16e-04 | 22 | 53 | 2 | 15767678 | ||
| Pubmed | WNT4 and RSPO1 together are required for cell proliferation in the early mouse gonad. | 5.16e-04 | 22 | 53 | 2 | 23095882 | |
| Pubmed | 6.20e-04 | 963 | 53 | 7 | 28671696 | ||
| Pubmed | 6.23e-04 | 255 | 53 | 4 | 15324660 | ||
| Pubmed | 7.00e-04 | 263 | 53 | 4 | 34702444 | ||
| Pubmed | 7.21e-04 | 467 | 53 | 5 | 30194290 | ||
| Pubmed | Tangential Intrahypothalamic Migration of the Mouse Ventral Premamillary Nucleus and Fgf8 Signaling. | 1.03e-03 | 31 | 53 | 2 | 34095148 | |
| Interaction | YWHAH interactions | KIAA1671 TANC2 NCOA3 DLG5 IRS4 FAM171A2 ALS2 MAP3K15 ARHGEF17 TRIP11 BICC1 PHLDB2 | 7.51e-06 | 1102 | 48 | 12 | int:YWHAH |
| Interaction | YWHAQ interactions | KIAA1671 TANC2 NCOA3 DLG5 IRS4 IGF1R FAM171A2 PKM ALS2 TRIP11 BICC1 PHLDB2 | 8.69e-06 | 1118 | 48 | 12 | int:YWHAQ |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q12 | 3.65e-05 | 8 | 53 | 2 | chr9q12 | |
| Cytoband | 9p13.1 | 3.55e-04 | 24 | 53 | 2 | 9p13.1 | |
| Cytoband | 15q22 | 5.20e-04 | 29 | 53 | 2 | 15q22 | |
| Cytoband | 10q22.3 | 1.15e-03 | 43 | 53 | 2 | 10q22.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q22 | 1.82e-03 | 208 | 53 | 3 | chr10q22 | |
| Cytoband | 19q13.3 | 4.09e-03 | 82 | 53 | 2 | 19q13.3 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.43e-04 | 66 | 28 | 3 | 722 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 6.25e-04 | 24 | 28 | 2 | 654 | |
| GeneFamily | Fibronectin type III domain containing | 1.89e-03 | 160 | 28 | 3 | 555 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.07e-06 | 153 | 53 | 5 | 4eb9c2d7e4b95d44198fc87dc115a08ef0153e26 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_ILC-NK_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.07e-06 | 153 | 53 | 5 | 26b5b45c117d155b028d298a0b93e16d343dca97 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_ILC|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.07e-06 | 153 | 53 | 5 | 0f12e38f2cbf69a520764289b0aa4dedc645f714 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.85e-06 | 171 | 53 | 5 | a4a2c5dc995589fbe3d4ca6ee1df888807e4ae34 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 3.02e-06 | 189 | 53 | 5 | f4865b7db16de15120504147a8016ac522ad242a | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.70e-06 | 197 | 53 | 5 | ee8f7def9d5af7b1e636830a4ea1da158d02f25a | |
| ToppCell | Kidney-Tubules|Kidney / Skin and Kidney Cells in Lupus Nephritis Patients. | 3.98e-06 | 200 | 53 | 5 | 0726456906e078244a9cff35aee8c5bce4566fb1 | |
| ToppCell | Tracheal-NucSeq-Stromal-Pericyte-Muscle_pericyte_systemic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.98e-06 | 200 | 53 | 5 | 9d3ae9ea47b1017adb63aa02d10e98193d478458 | |
| ToppCell | Tracheal-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.98e-06 | 200 | 53 | 5 | 78cd0b7d221ef855512ee9ac9a291f61622c2e24 | |
| ToppCell | Substantia_nigra|World / BrainAtlas - Mouse McCarroll V32 | 1.08e-05 | 115 | 53 | 4 | 18174b8d57d444fab1e9d2b13d22939c83c958e0 | |
| ToppCell | control-Lymphoid-NKT|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.79e-05 | 59 | 53 | 3 | 1c8c9032ce6e80f20c6462e1afbd2180c416f2cc | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-Double_negative_Thymocyte,_DN4_(Cd8-,_Cd4-),_some_undergoing_VDJ_recombination_|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-05 | 178 | 53 | 4 | 408e41c853f608965cef9111fb87fdc311cdc7a8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.23e-05 | 180 | 53 | 4 | 64956a85c404a2ea7e4eaf6f95ebcc52c198b7cc | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.52e-05 | 189 | 53 | 4 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 7.52e-05 | 189 | 53 | 4 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 7.52e-05 | 189 | 53 | 4 | 9c407b17d7945e81e1ae6c18452f5d20fb09d563 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 7.68e-05 | 190 | 53 | 4 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.68e-05 | 190 | 53 | 4 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | control-Myeloid-Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.83e-05 | 191 | 53 | 4 | db1b3cd07d7d190155b2d14e82e1d124975fbd0b | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 7.83e-05 | 191 | 53 | 4 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.15e-05 | 193 | 53 | 4 | 549a0b750c860b615aff767ad04c9a9d20f802f0 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.15e-05 | 193 | 53 | 4 | 7631bf3362b4fa061ffeab4879ab12c4708dc4c0 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.15e-05 | 193 | 53 | 4 | 8d15c63f2ae48d0a00d7ef5fdafa917ab8ad0571 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.32e-05 | 194 | 53 | 4 | 78dcb9d48259afabe73b41c5508a73a8d62339a4 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.32e-05 | 194 | 53 | 4 | a7731378f44ca1a229311686caf5740c742d21ba | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.32e-05 | 194 | 53 | 4 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.49e-05 | 195 | 53 | 4 | d760d1423f9a8a373fe7b250ea9b1d67a0c0059f | |
| ToppCell | control-immature_Neutrophil|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.65e-05 | 196 | 53 | 4 | e34fd3e7a5b1c22a81fd3208e6d58bdb846d51c4 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.65e-05 | 196 | 53 | 4 | 184104cbea0461dd2757668ab9755948ac7b585a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.65e-05 | 196 | 53 | 4 | bebb20dc210576101c317011e3afb59798f5d255 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.65e-05 | 196 | 53 | 4 | 8114e98923096c54b6834f21550c3061bab6773d | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.83e-05 | 197 | 53 | 4 | dfeb4a0eb4dfba90f4a3e6ba31e0ab0e4aba5849 | |
| ToppCell | ILEUM-inflamed-(8)_Pericytes|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.83e-05 | 197 | 53 | 4 | e04ac8575f66d798ddf2fd6d55d397a163b40732 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.00e-05 | 198 | 53 | 4 | f261a37dd07976548b897af86df1d1a0dc069889 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Pericytes|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.00e-05 | 198 | 53 | 4 | 5e274c5597d8720290d452465f0bd40637cb3f27 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.00e-05 | 198 | 53 | 4 | 7dd874b09c81cc512ccc1e9b65f290a5f94d736e | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.18e-05 | 199 | 53 | 4 | 9c2db0bb94cba71a3cc1827844da090e213e0258 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.18e-05 | 199 | 53 | 4 | 2e7f517c0444b4f29ff11c26ab32e9cc0f7e99ef | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.18e-05 | 199 | 53 | 4 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | cellseq2-Mesenchymal-Myocytic-Myocytic_2-VSMC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.36e-05 | 200 | 53 | 4 | fc802dd73f048881d9ddafd1b79ab3ca654510e2 | |
| ToppCell | cellseq2-Mesenchymal-Myocytic-Myocytic_2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.36e-05 | 200 | 53 | 4 | cffddb39960cd611428397c1ec4023192e8af5a7 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 9.36e-05 | 200 | 53 | 4 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | cellseq2-Mesenchymal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.36e-05 | 200 | 53 | 4 | 6b558cce0d6047c7e85f428adff80c5ca3084ea4 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.36e-05 | 200 | 53 | 4 | 8a4c210a3130f7baedf15ecbc0f4903b97da0352 | |
| ToppCell | cellseq2-Mesenchymal-Myocytic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.36e-05 | 200 | 53 | 4 | e60aebd20be8012fa2febf6585ed34ebd64ec9b3 | |
| Disease | Endometrial Stromal Sarcoma | 2.69e-05 | 5 | 49 | 2 | C0206630 | |
| Disease | Clear cell sarcoma of kidney | 4.04e-05 | 6 | 49 | 2 | C0334488 | |
| Disease | mitochondrial myopathy (implicated_via_orthology) | 4.04e-05 | 6 | 49 | 2 | DOID:699 (implicated_via_orthology) | |
| Disease | glucose metabolism disease (implicated_via_orthology) | 9.93e-04 | 28 | 49 | 2 | DOID:4194 (implicated_via_orthology) | |
| Disease | response to angiotensin receptor blocker | 1.14e-03 | 30 | 49 | 2 | EFO_0010735 | |
| Disease | Squamous cell carcinoma of lung | 1.30e-03 | 32 | 49 | 2 | C0149782 | |
| Disease | Global developmental delay | 1.42e-03 | 133 | 49 | 3 | C0557874 | |
| Disease | Developmental delay (disorder) | 1.73e-03 | 37 | 49 | 2 | C0424605 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 2.28e-03 | 157 | 49 | 3 | DOID:14330 (implicated_via_orthology) | |
| Disease | anthropometric measurement | 2.76e-03 | 168 | 49 | 3 | EFO_0004302 | |
| Disease | pulmonary function measurement, smoking behaviour measurement, FEV/FEC ratio | 2.78e-03 | 47 | 49 | 2 | EFO_0003892, EFO_0004713, EFO_0005671 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GKLTSSSPSMFIGQW | 1141 | Q96Q42 | |
| PVMGWTAATGSLDAG | 296 | Q12887 | |
| KAISPSEGWTTGGAM | 256 | Q9HAK2 | |
| ELLPSPSGSLNWTMG | 336 | O94985 | |
| NTWSGLGFSKSMPAE | 756 | Q9H694 | |
| LLSATSNKWPMGGSG | 86 | Q6HA08 | |
| LNSSGSSWVSLPGKM | 951 | Q96QP1 | |
| ATVASGISPGWMGLD | 301 | P07205 | |
| GKMFIGGLSWQTSPD | 21 | Q96DH6 | |
| GLGTTGMWRPLSSSS | 661 | Q96PE2 | |
| TGAGSSAAPTMWLGA | 961 | Q9UPT6 | |
| WKESANKMSPSGGAP | 1146 | Q9BY89 | |
| NGLGSPFGKWTLSSA | 476 | Q9P107 | |
| WCGGLSLSTGMQVPS | 491 | Q9BXM9 | |
| AQSGMWKGNSPAGSQ | 21 | Q5U4P2 | |
| WKGNSPAGSQGAAME | 26 | Q5U4P2 | |
| MKSGSGGGSPTSLWG | 1 | P08069 | |
| SGAGSGPWIKNMERA | 976 | Q86YR7 | |
| PGTMGASSGVRLWAT | 1436 | P39060 | |
| SNSGGTWPKAMLSST | 941 | Q8TDM6 | |
| VLTGWRPGSGFTNTM | 511 | P14618 | |
| KAMTGSWAATPPSQG | 336 | P46093 | |
| PNQLTTMGSSLGTGW | 201 | Q99853 | |
| LTGLMWAQQGTTPGT | 116 | Q13724 | |
| ASSSGNGSWLELMPL | 196 | A8MVW0 | |
| MASSPGRGGISWQSS | 241 | Q14781 | |
| TSKALGPSQLRGMWT | 51 | Q10981 | |
| GGPSSSSMVWQVLEG | 81 | Q2VPK5 | |
| SLFLKSPLGSWNGSG | 6 | Q16584 | |
| TALIGTGSSCPGAMW | 41 | O14654 | |
| GGSLSALLRSKWGPM | 731 | Q6ZN16 | |
| LLPSSWKGNSGSCLM | 31 | Q8IVF1 | |
| LLPSSWKGNSGSCLM | 31 | A6NNL0 | |
| LLPSSWKGNSGSCLM | 31 | B1AL46 | |
| RDMGSKGGSWAAPSL | 241 | Q2TAK8 | |
| AKGKPSPWQSSMSTG | 636 | Q8IWB4 | |
| SSGDWGLPNSKAGRM | 916 | Q9Y6Q9 | |
| EMKGWPSGNLARNSS | 1361 | Q9Y6Q9 | |
| KGAKIGPATWAMATS | 1221 | Q9HCD6 | |
| MPSGGKVPWSLKNSS | 431 | Q9NT68 | |
| LLAMWNGSSLSDAGP | 176 | Q86SQ0 | |
| SGTTNTMIPFGKGWS | 926 | Q96KW2 | |
| AKGKPSPWQSSMSTG | 636 | Q5VYP0 | |
| TGPAGAMNTLAWSKG | 326 | Q5JXA9 | |
| SPSWRLTGFSGMKGU | 46 | Q99611 | |
| AKGKPSPWQSSMSTG | 636 | Q5TZJ5 | |
| AKGKPSPWQSSMSTG | 636 | Q5VU36 | |
| GAATGAALGSLMWSP | 226 | Q9UF11 | |
| NSSPWSGLMALGNSR | 16 | Q8TCJ2 | |
| MATPLGWSKAGSGSV | 1 | Q86W54 | |
| ASGMPLASLLWKSGP | 71 | Q9H269 | |
| TALAWSPNGMKLFSG | 131 | O15040 | |
| MSSWLGGLGSGLGQS | 1 | Q15643 | |
| STQTSSLNMLKGPWG | 741 | Q502W6 | |
| SMTLGWKVPKFSGGS | 726 | P54296 |